Mannatech (NASDAQ:MTEX) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX) in a research report report published on Tuesday. The firm issued a buy rating on the stock.

Mannatech Stock Performance

NASDAQ:MTEX opened at $8.50 on Tuesday. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.25 and a quick ratio of 0.74. The firm has a market capitalization of $15.98 million, a price-to-earnings ratio of -10.49 and a beta of 1.17. The company’s 50-day moving average is $7.88 and its two-hundred day moving average is $7.57. Mannatech has a 1-year low of $6.75 and a 1-year high of $10.51.

Mannatech (NASDAQ:MTEX) last posted its earnings results on Tuesday, November 12th. The company reported ($0.17) earnings per share for the quarter. The firm had revenue of $31.73 million during the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%.

Insider Buying and Selling at Mannatech

In other news, Director Larry A. Jobe sold 16,288 shares of the company’s stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $7.75, for a total value of $126,232.00. Following the transaction, the director now directly owns 54,721 shares in the company, valued at approximately $424,087.75. This represents a 22.94 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 41.50% of the stock is currently owned by company insiders.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.